Cargando…

Trends of Rifampicin Resistance in Patients with Pulmonary Tuberculosis: A Longitudinal Analysis Based on Drug Resistance Screening in Eastern China Between 2015 and 2019

OBJECTIVE: To understand the trend of overall rifampicin resistance rates for tuberculosis in Zhejiang Province between 2015 and 2019. METHODS: The basic demographic information of patients with tuberculosis who were screened for drug resistance in Zhejiang Province between January 1, 2015 and Decem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Yanli, Chen, Bin, Zhao, Jiaying, Tan, Xiaohua, Chen, Xinyi, Zhou, Lin, Wang, Fei, Peng, Ying, Jiang, Jianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805726/ https://www.ncbi.nlm.nih.gov/pubmed/36597456 http://dx.doi.org/10.2147/IDR.S394089

Ejemplares similares

Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019
por: Su, Wei, et al.
Publicado: (2021)

Epidemiological Characteristics of Rifampicin-Resistant Tuberculosis in Students — China, 2015–2019
por: Su, Wei, et al.
Publicado: (2021)

Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015–2019
por: Wasihun, Araya Gebreyesus, et al.
Publicado: (2021)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Trends of Mycobacterium tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia
por: Abay, Getachew Kahsu, et al.
Publicado: (2020)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China
por: Liu, Zhengwei, et al.
Publicado: (2020)

Large gap between attitude and action in tuberculosis preventive treatment among tuberculosis-related healthcare workers in eastern China
por: Wang, Fei, et al.
Publicado: (2022)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China
por: Tong, Enyu, et al.
Publicado: (2023)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Chylothorax in a child with rifampicin-resistant tuberculosis
por: McLaren, B, et al.
Publicado: (2019)

Navigating a Path to Rifampicin Resistance in Tuberculosis
por: Agarwal, Sakshi, et al.
Publicado: (2023)

HIV-Negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A Clinical Retrospective Investigation Study from a National Tuberculosis Clinical Research Center
por: Ma, Jun, et al.
Publicado: (2022)

Prevalence of rifampicin resistant tuberculosis among pulmonary tuberculosis patients In Enugu, Nigeria
por: Ulasi, Amara, et al.
Publicado: (2022)

Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
por: Chen, Ling, et al.
Publicado: (2021)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

Dysphonia – the single symptom of rifampicin resistant laryngeal tuberculosis
por: Paulauskienė, Iveta, et al.
Publicado: (2016)

Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016–2020
por: Yang, Yunbin, et al.
Publicado: (2023)

1433. Factors Associated with Unsuccessful Treatment Outcomes among Patients with Rifampicin Resistant Tuberculosis - Tajikistan, 2015-2020
por: Tilloeva, Zulfiya Haybullo, et al.
Publicado: (2022)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Burden of Pulmonary Rifampicin-Resistant Tuberculosis in Kajiado, Kenya: An Observational Study
por: Cattaneo, Paolo, et al.
Publicado: (2023)

Tuberculosis/HIV Coinfection and Treatment Trends — China, 2015−2019
por: Liu, Eryong, et al.
Publicado: (2020)

Systematic Review of the Performance of Rapid Rifampicin Resistance Testing for Drug-Resistant Tuberculosis
por: Arentz, Matthew, et al.
Publicado: (2013)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015
por: Matambo, Ronnie, et al.
Publicado: (2020)

Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach
por: Kumar, Satish, et al.
Publicado: (2014)

Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods
por: Mwanza, Winnie, et al.
Publicado: (2018)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes
por: Katende, Bulemba, et al.
Publicado: (2020)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2022)

Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis
por: Spies, Ruan, et al.
Publicado: (2022)

Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China
por: Zhao, Bing, et al.
Publicado: (2022)

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis
por: Reuter, Anja, et al.
Publicado: (2023)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

848. Trends of Carbapenem Resistance in Enterobacterales in the US Between 2015 and 2019
por: Marcella, Stephen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_stfb3sekeg3npckhctnmq2kbgp